It is a chemicals private limited company based in Siliguri, West Bengal, India, established in 2022.
2022 | Siliguri, West Bengal, India | ActiveRevanex Pharmaceuticals Private Limited, a active private limited company, was established on 08 September 2022 in Siliguri, West Bengal, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24290WB2022PTC257023. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Kumari Kavita (Director), Babita Kumari (Director), Mita Mukhertee (Director). Past directors included Srimayee Bhadra. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 24, Uday Sankar Sarani, Deshbandhu Para,, Siliguri, Darjeeling, Siliguri(Po), Siliguri, West Bengal, 734004.
U24290WB2022PTC257023
257023
08 September 2022
₹0.10 M
₹0.10 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Revanex Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kumari Kavita | Director | 08 Sep 2022 | Current |
| Babita Kumari | Director | 08 Sep 2022 | Current |
| Mita Mukhertee | Director | 08 Sep 2022 | Current |
| Debopriya Bhadra | Director | 25 Aug 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Aug 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Revanex Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Revanex Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Revanex Pharmaceuticals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Revanex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Revanex Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Revanex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Debopriya Bhadra was appointed as a Director was appointed as a Director on 25 Aug 2024 & has been associated with this company since 1 year 3 months . was completed.
Revanex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was recorded as a recent event.
Progress on Kumari Kavita was appointed as a Director was appointed as a Director on 08 Sep 2022 & has been associated with this company since 3 years 2 months . was documented.
Progress on Babita Kumari was appointed as a Director was appointed as a Director on 08 Sep 2022 & has been associated with this company since 3 years 2 months . was documented.
The activity Mita Mukhertee was appointed as a Director was appointed as a Director on 08 Sep 2022 & has been associated with this company since 3 years 2 months . was completed.
The CIN of Revanex Pharmaceuticals Private Limited is U24290WB2022PTC257023.
Revanex Pharmaceuticals Private Limited is headquartered at 24, Uday Sankar Sarani, Deshbandhu Para,, Siliguri, Darjeeling, Siliguri(Po), Siliguri, West Bengal, 734004.
Revanex Pharmaceuticals Private Limited was incorporated on 08 September 2022.
The current directors of Revanex Pharmaceuticals Private Limited are
The primary industry of Revanex Pharmaceuticals Private Limited is Chemicals.
Revanex Pharmaceuticals Private Limited is unlisted.
The authorized capital of Revanex Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Revanex Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX